Expands Pfizer’s rare disease portfolio with potential first-in-class therapy for achondroplasia, a genetic condition and the most common form of short-limb dwarfism NEW YORK & BASEL, Switzerland–Pfizer (NYSE: PFE) today announced that it has entered into a definitive agreement to acquire all the shares of Therachon Holding AG, a privately-held clinical-stage biotechnology company focused on […]
Switzerland is home to hundreds of excellent startups. Every year the TOP 100 Swiss Startup Award showcases the 100 most-innovative and promising Swiss startups. The event, a unique opportunity to discover the best of Swiss innovation, sees a jury of 100 leading investors and experts rank the country’s most-impactful new high-tech companies. You can vote […]
Danuta Cichocka of HEMEX’s portfolio company Resistell AG had 90 seconds to explain what she does and how much money she needs to take her startup to the next level. She was one of four up-and-coming entrepreneurs who made the best pitch at the annual Startup Champions Seed Night. To the video
Marija Plodinec, CEO of Artidis (Img: Technologiepark Basel) “Artidis is based on the oldest diagnostic test on earth: palpation,” says Marija Plodinec, CEO and co-founder of Artidis AG. “In a nutshell, we palpate tissue on a molecular level,“ she adds with a twinkle. That’s because instead of a physician’s hand, Artidis runs a fine, high-precision […]
Hemex will attend the MedTech Summit which will take place in Brussels, Belgium on June 11-15, 2018. Contact Rosina Cifelli if you would like to meet with us. We look forward to discussing your project with you!
We would be delighted to meet with you at one of our offices in Europe or the US. Please let us know when/where you would like to visit us and we will make sure we are awaiting you. Click here for directions to our office.